Can highly regulated pharmaceutical companies use AI effectively? What are companies doing to leverage AI without compromising their CGMP-validated processes? Please join this practical, real-world conversation on moving AI beyond pilots and into meaningful results.
Tech-Clarity’s Julie Fraser joins with Kate Porter, Director of Product Management and Research at POMS, along with a customer. Roland Esquivel, POMS VP of Sales and Marketing will moderate the discussion and lend his experience also. This diverse panel will discuss what is already working and where regulatory, quality, IT, and other questions and challenges lie.
The discussion will touch on these topics:
- What pharma manufacturers are trying to achieve with AI and why outcomes vary
- Real-world examples of where AI is working today in manufacturing operations
- Lessons from AI initiatives that stalled or failed to scale
- Why Proof of Concept efforts often fall short and how to approach them differently
- The organizational elements successful teams put in place before AI scales
- Key questions leaders and teams should ask before investing in AI
- Technology insights from the field on what accelerates and what slows AI adoption
What is your experience with AI in your life sciences environment? What do you still need to know to move forward with AI?
Register here for this 1-hour event taking place March 4 at 6PM CET, 12PM Eastern, 9AM Pacific. Thank you to POMS Corporation for inviting us to share our research on this pharmaceutical-focused, panel discussion-style webinar.
